Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Saftey and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression

NCT06979544 is registered in ClinicalTrials.gov with Lipocine Inc. as lead sponsor.

NCT NCT06979544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06979544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Saftey and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Lead sponsor
Lipocine Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 16, 2025
Completion date
February 17, 2026
Enrollment
90 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

depression, post-partum, depression, postpartum, peripartum depression, post-natal depression, postnatal depression, postpartum depression (ppd)